Comprehensive Cell & Gene Therapy Manufacturing Services Market Insights: Forecasting Size, Growth, and Competitive Trends from 2025 to 2034

What market dynamics are playing a key role in accelerating the growth of the cell & gene therapy manufacturing services market?
The rise in the prevalence of cancer and other targeted diseases is predicted to drive the progression of the cell and gene therapy manufacturing services market. Cancer, a critical illness defined by the rapid and uncontrolled multiplication of the body cells leading to excessive growth, has triggered the development of cell and gene therapies. These innovative approaches are devised to battle the increasing occurrence of cancer and have led to a surge in the demand for unique and effective treatment alternatives. For instance, the American Cancer Society disclosed in January 2023 that the count of cancer patients rose from 1,898,160 in 2021 to 1,958,310 in 2023, resulting in a growth rate of 3.16%. Consequently, the escalating frequency of cancer and other target diseases is steering the expansion of the cell and gene therapy manufacturing services market.

Get Your Cell & Gene Therapy Manufacturing Services Market Report Here:
https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-manufacturing-services-global-market-report

How will the growth rate of the cell & gene therapy manufacturing services market shape industry trends by 2034?
Over the past years, the market size for cell & gene therapy manufacturing services has been significantly expanding. With a projected compound annual growth rate (CAGR) of 16.1%, it is anticipated to escalate from $8.15 billion in 2024 to $9.46 billion in 2025. Factors such as augmented R&D investments, the establishment of supporting regulatory frameworks, the burgeoning pipeline of cell and gene therapies, industry alliances and partnerships, as well as the rising worldwide demand for personalized medicine, have all contributed to the growth during the historical period.

We can anticipate a swift expansion in the market of cell & gene therapy manufacturing services in the upcoming years. The market is estimated to reach "$17.97 billion in 2029, growing at a compound annual growth rate (CAGR) of 17.4%. Factors contributing to this growth during the forecast period include the market reaching maturity and commercialization, expansion of biopharmaceutical manufacturing globally, increased outsourcing from pharmaceutical firms, advancements in robotics and automation, and the emergence of novel therapeutic modalities. The forecast period will also see major trends like growing demand for energy efficiency, advanced materials & technologies, compact & modular designs, and electrification of transportation along with an emphasis on safety and reliability.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10035&type=smp

What trends are poised to drive the future success of the cell & gene therapy manufacturing services market?
The emergence of technological advancements is a trend that is becoming increasingly popular in the market for cell and gene therapy manufacturing services. To maintain their market standing, many major corporations in this field are implementing new technologies. Charles River Laboratories International Inc., a pharmaceutical company based in the United States that offers a range of preclinical and clinical laboratory, gene therapy, and cell therapy services, exemplifies this trend. In October 2022, they launched the navigation Vector Platform (navigation). This platform simplifies the journey toward GMP Adeno-Associated Virus (AAV) vector manufacturing, eliminating the need for extensive process development. Compared to traditional manufacturing processes, the navigation platform can accelerate a viral vector gene therapy researcher's shift to GMP by 55%. Charles River's navigation method operates on a distinctive, high-efficiency HEK293 suspension cell line that can be amplified and serotyped to suit the needs of their customers.

Which primary segments of the cell & gene therapy manufacturing services market are driving growth and industry transformations?
The cell & gene therapy manufacturing services market covered in this report is segmented -

1) By Type: Gene Therapy, Cell Therapy
2) By Indication: Central Nervous System Disorders, Ophthalmology Diseases, Cardiovascular Diseases, Infectious Diseases, Orthopedic Diseases, Oncology Diseases
3) By Application: Commercial Manufacturing, Clinical Manufacturing
4) By End-user: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:
1) By Gene Therapy: Viral Vector Manufacturing, Plasmid DNA Production, Gene Editing Services, Formulation And Fill-Finish Services
2) By Cell Therapy: Cell Sourcing And Banking, Cell Processing And Expansion, Quality Control And Testing Services, Cryopreservation And Storage Services

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10035

Which geographical regions are pioneering growth in the cell & gene therapy manufacturing services market?
North America was the largest region in the cell and gene therapy manufacturing services market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global cell & gene therapy manufacturing services market report forecast period. The regions covered in the cell & gene therapy manufacturing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Who are the influential players reshaping the cell & gene therapy manufacturing services market landscape?
Major companies operating in the cell & gene therapy manufacturing services market include Thermo Fisher Scientific Inc., Merck KGaA, Charles River Laboratories International Inc., Lonza Group AG, Catalent Inc., WuXi AppTec, Takara Bio Inc., Nikon Corporation, Fujifilm Holdings Corporation, F. Hoffmann-La Roche Ltd, Oxford Biomedica plc, CGT Catapult, bluebird bio Inc., Boehringer Ingelheim International GmbH, Innovative Cellular Therapeutics Co. Ltd., Samsung Biologics Co. Ltd., Novartis International AG, Pfizer Inc., Brammer Bio, AGC Biologics, Cognate BioServices Inc., Paragon Bioservices Inc., Merck KGaA operating as MilliporeSigma, Sarepta Therapeutics Inc., Spark Therapeutics Inc., Orchard Therapeutics plc, Precision BioSciences Inc., PCT a Hitachi Group Company, Aldevron LLC, BioNTech SE

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=10035&type=smp

What Is Covered In The Cell & Gene Therapy Manufacturing Services Global Market Report?

• Market Size Forecast: Examine the cell & gene therapy manufacturing services market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the cell & gene therapy manufacturing services market for a structured understanding.
• Key Players Overview: Analyze major players in the cell & gene therapy manufacturing services market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the cell & gene therapy manufacturing services market.
• Segment Contributions: Evaluate how different segments drive overall growth in the cell & gene therapy manufacturing services market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the cell & gene therapy manufacturing services market.
• Industry Challenges: Identify potential risks and obstacles affecting the cell & gene therapy manufacturing services market.
• Competitive Landscape: Review strategic developments in the cell & gene therapy manufacturing services market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.